Tag: Prescription Drugs
Off-Label Uses in Dermatology Often Missing From Compendia
Only 30.7 percent of 238 treatments used to treat 22 dermatologic conditions listed in compendia
NOACs Recommended as First-Line Prevention of Stroke in A-Fib
Updated guidelines also emphasize weight loss for overweight, obese patients with atrial fibrillation
Risk for Conversion of MS Varies With Different Therapies
Lower risk for conversion for initial treatment with fingolimod, alemtuzumab, or natalizumab
2003 to 2015 Saw Increase in Outpatient Benzodiazepine Use
Fourfold increase seen in rate of coprescribing with opioids; twofold increase with other sedating meds
Levodopa + Carbidopa Does Not Modify Disease in Early Parkinson
Findings in patients with early Parkinson disease evaluated over the course of 80 weeks
Benzodiazepine, Opioid Co-Usage Up in the United States
Increases also noted in co-use of nonselective and selective benzodiazepine receptor modulators
Oral Hepatoselective Glucokinase Activator Promising in T2DM
Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399
FDA Panel Has Tie Vote on New Type 1 Diabetes Drug
Zynquista is a once-daily pill meant to help type 1 diabetes patients manage their blood glucose levels
Medication Treatment for Substance Abuse Up in Facilities
2007 to 2016 saw increase in use of medication treatment, reaching 36.1 percent in 2016
Ertugliflozin Seems Safe, Effective for Type 2 Diabetes Treatment
Improvements seen in HbA1c, fasting glucose, body weight, blood pressure over two years
